A documentary on Cuban cancer vaccines to be shown in Canada

Source: Chamosaurio
September 17 2020

This Saturday, Canadian state broadcaster CBC will air the documentary Cuban Hope Against Cancer, which highlights the island’s progress in developing lung cancer vaccines.

The film, which premiered on PBS in North America in April this year, focuses on the Cuban drugs CIMAVax and Vaxira and the collaboration between the Antilles and the United States.

Can a lung cancer vaccine give hope to patients around the world? Innovative therapies developed in Cuba are transforming some cancers, from life-threatening illnesses to chronic conditions like diabetes or high blood pressure, the CBC reports on its website.

Cuba’s Cancer Hope explores the story of how the island became a leader in biomedical research and tells the journey of two patients, one from the island and the other from the United States, who received vaccines. The network announced the screening of the documentary on September 19 at 22:00 local time in the capital.

“In both Cuba and the United States, lung cancer is a leading cause of death. But after decades of the United States trade embargo (blockade), Cuba was economically and politically isolated and lacked medical resources, ”the statement said.

Cuban scientists have been forced to get creative with their own immunotherapy drugs. Among them, he noted, there are lung cancer vaccines that can help trigger the body’s immune response to cancer.

The CBC added that these treatments are so promising that some American patients are even defying the economic, trade and financial blockade imposed by Washington nearly 60 years ago “to travel to Cuba for treatment.”

The announcement also highlights that scientists from the Caribbean country are collaborating with the leading cancer research institute in the United States to develop an even more effective treatment that combines the best research and medical technologies from both countries.

Thus, he refers to the fact that in September 2018, Roswell Park Comprehensive Cancer Center in New York and the Cuba Center for Molecular Immunology announced the creation of Innovative Immunotherapy Alliance SA, the first Cuban-American biotechnology company.

“The goal is to make medicines more affordable, but will the embargo get in the way?” Asked the CBC.

Tpl / mar

from Blogger https://ift.tt/3iB3xSu
via IFTTT

Cuba Develops Four Cancer Vaccines, Ignored by the Media

Source:  Cubainformacion

The fact that Cuba has already developed four cancer vaccines undoubtedly is big news for humanity if you bear in mind that according to the World Health Organization nearly 8 million people die from that disease every year. However, the mainstream media have completely ignored this reality.

In 2012, Cuba patented the first therapeutic vaccine in the world against advanced lung cancer, called CIMAVAX-EGF.  In January 2013, the island announced the second cancer vaccine, known as Racotumomab.

Clinical tests, carried out in 86 nations, revealed that though these vaccines do not cure the disease, they do reduce the tumors thus improving the quality and expectancy of life of the patients.

Vaccines developed by Cuba’s Molecular Immunology Centre

The Havana-based Molecular Immunology Center is the creator of these vaccines. The center had already developed the Meningitis-B Vaccine in 1985, one of its kind in the world. Later there came other vaccines, such as the Hepatitis-B and the Dengue. Experts at the entity have been researching for years on a HIV-Aids vaccine as well.

The Cuban agenda against cancer is also joined by Labiofam pharmaceutical enterprise, which develops homeopathic medications against the disease, such as VIDATOX, made from the venom of blue scorpion, native of Cuba.

At present, Cuba exports these products to 26 countries and participates in joint ventures in China, Canada and Spain. This breaks the extended media silence about the advancements of Cuba and other South countries in the field, and the largely voiced stereotype that advanced pharmaceutics is only developed in the developed countries, however.

 Cuba’s research philosophy opposes the market policies of the big pharmaceutical industry